The effectiveness and value of tezepelumab for severe asthma: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

Detalles Bibliográficos
Autores principales: Rind, David M, McQueen, R. Brett, Herron-Smith, Serina, Herce-Hagiwara, Belén, Gutierrez, Eric, Campbell, Jon D, Fluetsch, Noemi, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373025/
https://www.ncbi.nlm.nih.gov/pubmed/35471071
http://dx.doi.org/10.18553/jmcp.2022.28.5.577
Descripción
Sumario:

Ejemplares similares